Analysis of efficacy and prognostic factors in second-line chemotherapy for BRAF V600E mutant metastatic colorectal cancer

Authors :: Takashi Ura
Toshiki Masuishi
K. Muro
Yukiya Narita
M. Ando
Shigenori Kadowaki
Hiroya Taniguchi
Seiichiro Mitani
Kazufumi Honda
Masahiro Tajika
Source :: Annals of Oncology. 28:v180
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: BRAF V600E
Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Internal medicine
Mutant
Medicine
Hematology
business
medicine.disease
Second line chemotherapy

Full Text Access

Tools